Navigation Links
CVS/pharmacy's Transportation Operations Receives Two National Safety Awards
Date:10/8/2009

WOONSOCKET, R.I., Oct. 8 /PRNewswire/ -- CVS/pharmacy was recently honored by two transportation trade associations with national safety awards for the transportation operations of its Logistics Department. The Company received the American Trucking Association's (ATA) 2009 President's Trophy in the "Under 25 Million Miles" category. In addition, the National Private Truck Council (NPTC) selected Ralph Haynes, a driver based in CVS/pharmacy's Knoxville, TN distribution center as one of its 2009 National Driver All-Stars.

The ATA President's Trophy is the highest safety award available to motor carriers in the United States and is presented annually to only three carriers, one in each of three categories: Under 25 Million Miles, 25-100 Million Miles and Over 100 Million Miles. CVS/pharmacy's transportation operations were judged the most outstanding for Under 25 Million Miles on the basis of its safety record, programs and community outreach activities.

NPTC's National Driver All-Stars were recognized during its National Safety Conference and were selected based on their meeting high performance standards in the fields of customer service, safety and compliance. Haynes was one of just 12 private fleet truck drivers to be selected this year.

"We are very proud to receive this recognition from the ATA and the NPTC, two well-respected trade associations in our industry," said Ron Link, Senior Vice President of Logistics at CVS/pharmacy. "Ralph Haynes is well-deserving of his All-Star award. He embodies our mission to support our stores' fulfillment needs with a high level of customer service while ensuring the safety of our fleet and our transportation associates."

About CVS/pharmacy

CVS/pharmacy, the retail division of CVS Caremark Corporation, is America's leading retail pharmacy with more than 7,000 CVS/pharmacy and Longs Drug stores. CVS/pharmacy is committed to improving the lives of those we serve by making innovative and high-quality health and pharmacy services safe, affordable and easy to access, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Caremark is available at www.cvscaremark.com.

    CONTACT:
    Mike DeAngelis
    CVS/pharmacy
    401-770-2645

SOURCE CVS/pharmacy


'/>"/>
SOURCE CVS/pharmacy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
2. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
3. Premier Research Expands its Medical Device Operations to the United States
4. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
5. Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico, Turkey and Five Other Countries in Europe
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
11. CryoCor Receives FDA Approval for Right Atrial Flutter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):